Capital Change Notice

12
th
October 2021

Notice of issue of ordinary shares under Rua Bioscience Limited’s share option plan

This notice is given under NZX Listing Rules 3.13.1 and 3.15.2 and relates to the issue of fully paid ordinary
shares in Rua Bioscience Limited (the Company) upon exercise of vested options issued and granted under
the share option plan of the Company (the Share Option Plan).

Under the Share Option Plan, one vested option will convert into 5.882 ordinary shares upon exercise.

This notice provides details of the issue of 1,417,856 ordinary shares in the Company upon exercise of
options granted to selected eligible employees of the Company pursuant to the rules of the Share Option
Plan.

Section 1: Issuer information
Name of issuer Rua Bioscience Limited
NZX ticker code RUA
Class of Security Ordinary Shares
ISIN NZRUAE0004S1
Section 2: Capital change details
Number issued 1,417,856
Issue price per Security No cash consideration is payable
for the issue of the Ordinary
Shares
Nature of the payment (for example, cash or other consideration) Not applicable
Amount paid up Fully paid
Percentage of total class of Securities issued 1.01% (of the total number of
Ordinary Shares in Rua on issue
immediately prior to completion
of the issue)
Reason for issue Issue of ordinary shares upon
exercise of options pursuant to
the Share Option Plan.
Total number of securities of the Class in existence after the issue
141,739,267 Ordinary Shares
following the issue
Specific authority for the issue
Resolution of Directors’ upon
granting of options and
subsequently to account for a
MARKET ANNOUNCEMENT

“share split”. The Shares were
issued in accordance with Listing
Rule 4.6.
Terms of the issue
Terms of the Share Option Plan.
The issued shares will rank
equally in all respects with the
other fully paid ordinary shares
on issue.
Date of issue 12
th
October 2021
Details of interest of dividend conditions attaching to securities
converted and allotted on conversion
Nil
Number of securities of the same class still to be converted Nil
Section 3: Authority for this announcement and contact person
Name of person authorised to make this announcement
Hamish White, Chief Financial
Officer of Rua Bioscience Limited
Contact person for this announcement Kerry Donovan
Contact phone number +64 21 128 7689
Contact email address Kerry.donovan@ruabio.com
Date of release through MAP 12
th
October 2021